Pegasus Asset Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-10,000
| Closed | -$22.9K | – | 72 |
|
|
2023
Q2 | $22.9K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2023
Q1 | $24.3K | Hold |
10,000
| – | – | 0.01% | 70 |
|
|
2022
Q4 | $19.1K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2022
Q3 | $24K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2022
Q2 | $19K | Hold |
10,000
| – | – | 0.01% | 72 |
|
|
2022
Q1 | $21K | Hold |
10,000
| – | – | 0.01% | 77 |
|
|
2021
Q4 | $39K | Hold |
10,000
| – | – | 0.02% | 76 |
|
|
2021
Q3 | $48K | Hold |
10,000
| – | – | 0.02% | 76 |
|
|
2021
Q2 | $46K | Hold |
10,000
| – | – | 0.02% | 74 |
|
|
2021
Q1 | $59K | Hold |
10,000
| – | – | 0.03% | 73 |
|
|
2020
Q4 | $34K | Hold |
10,000
| – | – | 0.02% | 71 |
|
|
2020
Q3 | $14K | Hold |
10,000
| – | – | 0.01% | 71 |
|
|
2020
Q2 | $20K | Hold |
10,000
| – | – | 0.01% | 70 |
|
|
2020
Q1 | $20K | Hold |
10,000
| – | – | 0.02% | 66 |
|
|
2019
Q4 | $42K | Hold |
10,000
| – | – | 0.03% | 71 |
|
|
2019
Q3 | $30K | Hold |
10,000
| – | – | 0.02% | 69 |
|
|
2019
Q2 | $63K | Hold |
10,000
| – | – | 0.05% | 68 |
|
|
2019
Q1 | $56K | Hold |
10,000
| – | – | 0.05% | 66 |
|
|
2018
Q4 | $66K | Buy |
+10,000
| New | +$66K | 0.06% | 67 |
|